New Animal Drugs for Use in Animal Feeds; Melengestrol; Monensin; Tylosin
other · Food and Drug Administration · Rule · Published 2009-11-23 · Effective 2009-11-23 · 74 FR 61029
Document
Document number
E9-28019
Federal Register citation
74 FR 61029
CFR reference
21 CFR 558
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2009-11-23
Effective date
2009-11-23
HHS docket
Docket No. FDA-2009-N-0665
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The supplemental NADA provides for use of the same dose levels approved for single-ingredient Type C medicated feeds containing melengestrol acetate, monensin, or tylosin phosphate for heifers fed in confinement for slaughter in three-way, combination drug Type C medicated feeds containing melengestrol acetate, monensin, and tylosin phosphate.